The Pharmalytics No. 7 – Q1 2026 edition is now available, providing a focused analysis of the developments shaping pharmaceutical and MedTech logistics in the first quarter of 2026.
This edition captures a shift in how the industry must interpret disruption. What was once treated as episodic is increasingly becoming structural. The combination of geopolitical tension, constrained transport capacity, and evolving market strategies is placing sustained pressure on global supply chains.
Q1 2026 – Key Insights & Expert Perspectives
-
Editorial Column: Resilience must not become the next buzzword
From “responsibility on wheels” to systemic fragility: what happens when control limits flexibility - Rewiring global pharmaceutical trade: How geopolitics, supply chain resilience, and strategic control are reshaping a $900 billion global market in 2025-2026.
- Precision over scale: How pharma supply chains are evolving in 2026 – an overview of the most impactful developments in pharma logistics during Q1 2026
- Pharma Market Developments | Focus on the global generic medicines sector: from globalisation to market dependency, what are the future trajectories?
Accessing the Report
The Pharmalytics Q4 2025 report is available exclusively to Pharma.Aero members via the secure members’ area. This public article serves as an overview only; detailed data, analysis, and insights remain confidential.